Transplanting stem-cell derived dopamine progenitor cells into the brain to treat Parkinson’s disease is feasible, a landmark study has shown. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during the first year of follow‑up.
Cambridge scientists have grown miniature circuits in the lab that mimic how the brain and spinal cord connect up, which underlies our movements. They used this model to show how damage to these connections previously considered ‘irreversible’ could, in fact, be reversible.
Eight scientists from the fields of biomedical and health research at the University of Cambridge have been elected as Fellows of the Academy of Medical Sciences.
Damage to white matter in the brain can trigger features associated with neurodegenerative disease, Cambridge researchers have discovered in a new study published in the journal Nature.
Cambridge scientists have shown that when tumours first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced stages of disease.
Meet the winners of the Cambridge Awards 2025 for Research Impact and Engagement and learn more about their projects.
The collaboration will use state-of-the-art genomics approaches in combination with machine learning methods to advance our scientific understanding of cells and tissues in health and disease.
Centre for Children's Gut Health aims to transform the physical and mental health of children and young people.
A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists.
Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease, a study in mice has suggested. Further research in clinical trials will be needed to confirm this works for patients.
© 2026 University of Cambridge